Contact this trialFirst, we need to learn more about you.
Alkylating agents
Reduced-Intensity Chemoradiotherapy for Oropharyngeal Cancer
Recruiting1 awardPhase 2
High Point, North Carolina
This trial is testing a lower-intensity radiation and chemotherapy regimen to treat HPV-associated head and neck cancers. The goal is to see if it is as effective as the current standard of care while causing fewer side effects.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.